Report Detail
Global PD-L1 and PIK3CA Testing Supply, Demand and Key Producers, 2026-2032
- RnM4667313 |
- 22 January, 2026 |
- Global |
- 108 Pages |
- GIR |
- Pharma & Healthcare
The global PD-L1 and PIK3CA Testing market size is expected to reach $ 3077 million by 2032, rising at a market growth of 16.5% CAGR during the forecast period (2026-2032).
PD-L1 Biomarker Testing measures the amount of PDL1 on cancer cells. PDL1 is a protein that helps keep immune cells from attacking nonharmful cells in the body. Normally, the immune system fights foreign substances like viruses and bacteria, and not your own healthy cells. Some cancer cells have high amounts of PDL1. This allows the cancer cells to "trick" the immune system, and avoid being attacked as foreign, harmful substances. Current PD-L1 testing is based on immunohistochemistry (IHC) methods. Immunohistochemistry (IHC) is the process whereby antibodies are used to detect proteins (antigens) in cells within a tissue section (for instance liver, pancreas or the heart). PD-L1 is a ligand that binds to PD-1 (programmed cell death-1), expressed on activated T cells, to evade anti-tumor responses. PD-L1 plays a role in inhibiting T cell activation and proliferation and has emerged as an important target in cancer treatment. PD-L1 protein detection by immunohistochemistry (IHC) testing is widely used as a predictive biomarker assay for anti–PD-1/PD-L1 therapies. PIK3CA is a gene that encodes a lipid kinase involved in multiple signaling pathways. These pathways influence cellular functions such as growth, death, and proliferation. PIK3CA mutations activate the PI3K-PTEN-AKT pathway, which is downstream from both the EGFR and the RAS-RAF-MAPK pathways. PIK3CA mutations may cause oncogenic transformation independent of RAS or RAF mutations. PIK3CA mutations occur in about 15% to 30% of breast, endometrial, and colon cancers. They occur less frequently in lung cancer and other types of cancer. Presence of PIK3CA mutations is associated with poor prognosis and lack of response to specific therapies in patients with breast, endometrial, or colon cancer.
The global PD-L1 and PIK3CA testing market is experiencing robust growth, driven by the expanding use of precision oncology and the approval of targeted therapies across various cancer types, including NSCLC, breast, and cervical cancers. The increasing demand for companion diagnostics (CDx) in tandem with immunotherapies and PI3K inhibitors is accelerating the adoption of PD-L1 IHC assays and PIK3CA mutation tests. Additionally, government-backed initiatives for cancer screening, advancements in next-generation sequencing (NGS) platforms, and the growing integration of biomarkers into clinical decision-making are fostering greater clinical reliance on these tests. Leading pharmaceutical companies are also investing heavily in clinical trials that necessitate biomarker-based patient stratification, further boosting market penetration.
Despite the growth, the PD-L1 and PIK3CA testing market faces several challenges. Variability in test interpretation, lack of assay standardization, and the complexity of tumor heterogeneity often lead to inconsistent clinical outcomes, hampering trust in testing results. Regulatory hurdles for companion diagnostics, especially in emerging markets, and the high cost of NGS-based platforms pose barriers to adoption. Moreover, reimbursement uncertainty and disparities in healthcare infrastructure limit access in low-to-middle-income regions. The market is also affected by the evolving landscape of oncology diagnostics, where novel biomarkers and multi-gene panels may shift clinical focus away from single-analyte tests like PD-L1 or PIK3CA.
This report studies the global PD-L1 and PIK3CA Testing demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for PD-L1 and PIK3CA Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of PD-L1 and PIK3CA Testing that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global PD-L1 and PIK3CA Testing total market, 2021-2032, (USD Million)
Global PD-L1 and PIK3CA Testing total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: PD-L1 and PIK3CA Testing total market, key domestic companies, and share, (USD Million)
Global PD-L1 and PIK3CA Testing revenue by player, revenue and market share 2021-2026, (USD Million)
Global PD-L1 and PIK3CA Testing total market by Type, CAGR, 2021-2032, (USD Million)
Global PD-L1 and PIK3CA Testing total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global PD-L1 and PIK3CA Testing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Agilent Technologies, Roche, QIAGEN, EntroGen, Amoy Diagnostics, ACCB Biotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world PD-L1 and PIK3CA Testing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global PD-L1 and PIK3CA Testing Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global PD-L1 and PIK3CA Testing Market, Segmentation by Type:
PD-L1 Testing
PIK3CA Testing
Global PD-L1 and PIK3CA Testing Market, Segmentation by Application:
Hospital
Diagnostic Center
Others
Companies Profiled:
Agilent Technologies
Roche
QIAGEN
EntroGen
Amoy Diagnostics
ACCB Biotech
Key Questions Answered
1. How big is the global PD-L1 and PIK3CA Testing market?
2. What is the demand of the global PD-L1 and PIK3CA Testing market?
3. What is the year over year growth of the global PD-L1 and PIK3CA Testing market?
4. What is the total value of the global PD-L1 and PIK3CA Testing market?
5. Who are the Major Players in the global PD-L1 and PIK3CA Testing market?
6. What are the growth factors driving the market demand?
1 Supply Summary
- 1.1 PD-L1 and PIK3CA Testing Introduction
- 1.2 World PD-L1 and PIK3CA Testing Market Size & Forecast (2021 & 2025 & 2032)
- 1.3 World PD-L1 and PIK3CA Testing Total Market by Region (by Headquarter Location)
- 1.3.1 World PD-L1 and PIK3CA Testing Market Size by Region (2021-2032), (by Headquarter Location)
- 1.3.2 United States Based Company PD-L1 and PIK3CA Testing Revenue (2021-2032)
- 1.3.3 China Based Company PD-L1 and PIK3CA Testing Revenue (2021-2032)
- 1.3.4 Europe Based Company PD-L1 and PIK3CA Testing Revenue (2021-2032)
- 1.3.5 Japan Based Company PD-L1 and PIK3CA Testing Revenue (2021-2032)
- 1.3.6 South Korea Based Company PD-L1 and PIK3CA Testing Revenue (2021-2032)
- 1.3.7 ASEAN Based Company PD-L1 and PIK3CA Testing Revenue (2021-2032)
- 1.3.8 India Based Company PD-L1 and PIK3CA Testing Revenue (2021-2032)
- 1.4 Market Drivers, Restraints and Trends
- 1.4.1 PD-L1 and PIK3CA Testing Market Drivers
- 1.4.2 Factors Affecting Demand
- 1.4.3 Major Market Trends
2 Demand Summary
- 2.1 World PD-L1 and PIK3CA Testing Consumption Value (2021-2032)
- 2.2 World PD-L1 and PIK3CA Testing Consumption Value by Region
- 2.2.1 World PD-L1 and PIK3CA Testing Consumption Value by Region (2021-2026)
- 2.2.2 World PD-L1 and PIK3CA Testing Consumption Value Forecast by Region (2027-2032)
- 2.3 United States PD-L1 and PIK3CA Testing Consumption Value (2021-2032)
- 2.4 China PD-L1 and PIK3CA Testing Consumption Value (2021-2032)
- 2.5 Europe PD-L1 and PIK3CA Testing Consumption Value (2021-2032)
- 2.6 Japan PD-L1 and PIK3CA Testing Consumption Value (2021-2032)
- 2.7 South Korea PD-L1 and PIK3CA Testing Consumption Value (2021-2032)
- 2.8 ASEAN PD-L1 and PIK3CA Testing Consumption Value (2021-2032)
- 2.9 India PD-L1 and PIK3CA Testing Consumption Value (2021-2032)
3 World PD-L1 and PIK3CA Testing Companies Competitive Analysis
- 3.1 World PD-L1 and PIK3CA Testing Revenue by Player (2021-2026)
- 3.2 Industry Rank and Concentration Rate (CR)
- 3.2.1 Global PD-L1 and PIK3CA Testing Industry Rank of Major Players
- 3.2.2 Global Concentration Ratios (CR4) for PD-L1 and PIK3CA Testing in 2025
- 3.2.3 Global Concentration Ratios (CR8) for PD-L1 and PIK3CA Testing in 2025
- 3.3 PD-L1 and PIK3CA Testing Company Evaluation Quadrant
- 3.4 PD-L1 and PIK3CA Testing Market: Overall Company Footprint Analysis
- 3.4.1 PD-L1 and PIK3CA Testing Market: Region Footprint
- 3.4.2 PD-L1 and PIK3CA Testing Market: Company Product Type Footprint
- 3.4.3 PD-L1 and PIK3CA Testing Market: Company Product Application Footprint
- 3.5 Competitive Environment
- 3.5.1 Historical Structure of the Industry
- 3.5.2 Barriers of Market Entry
- 3.5.3 Factors of Competition
- 3.6 Mergers & Acquisitions Activity
4 United States VS China VS Rest of World (by Headquarter Location)
- 4.1 United States VS China: PD-L1 and PIK3CA Testing Revenue Comparison (by Headquarter Location)
- 4.1.1 United States VS China: PD-L1 and PIK3CA Testing Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
- 4.1.2 United States VS China: PD-L1 and PIK3CA Testing Revenue Market Share Comparison (2021 & 2025 & 2032)
- 4.2 United States Based Companies VS China Based Companies: PD-L1 and PIK3CA Testing Consumption Value Comparison
- 4.2.1 United States VS China: PD-L1 and PIK3CA Testing Consumption Value Comparison (2021 & 2025 & 2032)
- 4.2.2 United States VS China: PD-L1 and PIK3CA Testing Consumption Value Market Share Comparison (2021 & 2025 & 2032)
- 4.3 United States Based PD-L1 and PIK3CA Testing Companies and Market Share, 2021-2026
- 4.3.1 United States Based PD-L1 and PIK3CA Testing Companies, Headquarters (States, Country)
- 4.3.2 United States Based Companies PD-L1 and PIK3CA Testing Revenue, (2021-2026)
- 4.4 China Based Companies PD-L1 and PIK3CA Testing Revenue and Market Share, 2021-2026
- 4.4.1 China Based PD-L1 and PIK3CA Testing Companies, Company Headquarters (Province, Country)
- 4.4.2 China Based Companies PD-L1 and PIK3CA Testing Revenue, (2021-2026)
- 4.5 Rest of World Based PD-L1 and PIK3CA Testing Companies and Market Share, 2021-2026
- 4.5.1 Rest of World Based PD-L1 and PIK3CA Testing Companies, Headquarters (Province, Country)
- 4.5.2 Rest of World Based Companies PD-L1 and PIK3CA Testing Revenue (2021-2026)
5 Market Analysis by Type
- 5.1 World PD-L1 and PIK3CA Testing Market Size Overview by Type: 2021 VS 2025 VS 2032
- 5.2 Segment Introduction by Type
- 5.2.1 PD-L1 Testing
- 5.2.2 PIK3CA Testing
- 5.3 Market Segment by Type
- 5.3.1 World PD-L1 and PIK3CA Testing Market Size by Type (2021-2026)
- 5.3.2 World PD-L1 and PIK3CA Testing Market Size by Type (2027-2032)
- 5.3.3 World PD-L1 and PIK3CA Testing Market Size Market Share by Type (2027-2032)
6 Market Analysis by Application
- 6.1 World PD-L1 and PIK3CA Testing Market Size Overview by Application: 2021 VS 2025 VS 2032
- 6.2 Segment Introduction by Application
- 6.2.1 Hospital
- 6.2.2 Diagnostic Center
- 6.2.3 Others
- 6.3 Market Segment by Application
- 6.3.1 World PD-L1 and PIK3CA Testing Market Size by Application (2021-2026)
- 6.3.2 World PD-L1 and PIK3CA Testing Market Size by Application (2027-2032)
- 6.3.3 World PD-L1 and PIK3CA Testing Market Size Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Agilent Technologies
- 7.1.1 Agilent Technologies Details
- 7.1.2 Agilent Technologies Major Business
- 7.1.3 Agilent Technologies PD-L1 and PIK3CA Testing Product and Services
- 7.1.4 Agilent Technologies PD-L1 and PIK3CA Testing Revenue, Gross Margin and Market Share (2021-2026)
- 7.1.5 Agilent Technologies Recent Developments/Updates
- 7.1.6 Agilent Technologies Competitive Strengths & Weaknesses
- 7.2 Roche
- 7.2.1 Roche Details
- 7.2.2 Roche Major Business
- 7.2.3 Roche PD-L1 and PIK3CA Testing Product and Services
- 7.2.4 Roche PD-L1 and PIK3CA Testing Revenue, Gross Margin and Market Share (2021-2026)
- 7.2.5 Roche Recent Developments/Updates
- 7.2.6 Roche Competitive Strengths & Weaknesses
- 7.3 QIAGEN
- 7.3.1 QIAGEN Details
- 7.3.2 QIAGEN Major Business
- 7.3.3 QIAGEN PD-L1 and PIK3CA Testing Product and Services
- 7.3.4 QIAGEN PD-L1 and PIK3CA Testing Revenue, Gross Margin and Market Share (2021-2026)
- 7.3.5 QIAGEN Recent Developments/Updates
- 7.3.6 QIAGEN Competitive Strengths & Weaknesses
- 7.4 EntroGen
- 7.4.1 EntroGen Details
- 7.4.2 EntroGen Major Business
- 7.4.3 EntroGen PD-L1 and PIK3CA Testing Product and Services
- 7.4.4 EntroGen PD-L1 and PIK3CA Testing Revenue, Gross Margin and Market Share (2021-2026)
- 7.4.5 EntroGen Recent Developments/Updates
- 7.4.6 EntroGen Competitive Strengths & Weaknesses
- 7.5 Amoy Diagnostics
- 7.5.1 Amoy Diagnostics Details
- 7.5.2 Amoy Diagnostics Major Business
- 7.5.3 Amoy Diagnostics PD-L1 and PIK3CA Testing Product and Services
- 7.5.4 Amoy Diagnostics PD-L1 and PIK3CA Testing Revenue, Gross Margin and Market Share (2021-2026)
- 7.5.5 Amoy Diagnostics Recent Developments/Updates
- 7.5.6 Amoy Diagnostics Competitive Strengths & Weaknesses
- 7.6 ACCB Biotech
- 7.6.1 ACCB Biotech Details
- 7.6.2 ACCB Biotech Major Business
- 7.6.3 ACCB Biotech PD-L1 and PIK3CA Testing Product and Services
- 7.6.4 ACCB Biotech PD-L1 and PIK3CA Testing Revenue, Gross Margin and Market Share (2021-2026)
- 7.6.5 ACCB Biotech Recent Developments/Updates
- 7.6.6 ACCB Biotech Competitive Strengths & Weaknesses
8 Industry Chain Analysis
- 8.1 PD-L1 and PIK3CA Testing Industry Chain
- 8.2 PD-L1 and PIK3CA Testing Upstream Analysis
- 8.3 PD-L1 and PIK3CA Testing Midstream Analysis
- 8.4 PD-L1 and PIK3CA Testing Downstream Analysis
9 Research Findings and Conclusion
10 Appendix
- 10.1 Methodology
- 10.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on PD-L1 and PIK3CA Testing. Industry analysis & Market Report on PD-L1 and PIK3CA Testing is a syndicated market report, published as Global PD-L1 and PIK3CA Testing Supply, Demand and Key Producers, 2026-2032. It is complete Research Study and Industry Analysis of PD-L1 and PIK3CA Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
